Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2026, the Compensation Committee of the ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) ('Crinetics”), a pharmaceutical company focused on the discovery, development ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at 8:30 ...

Viatris Inc. (NASDAQ:VTRS) also reported that the Japan Pharmaceuticals and Medical Devices Agency (PMDA) accepted its ...

Strong PALSONIFY U.S. Launch Execution Resulted in Unaudited and Preliminary Net Product Revenue of >$5 Million for Fourth-Quarter 2025, with ...

Facial flushing can feel confusing, embarrassing, or even alarming—especially when it seems to come out of nowhere. One ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

According to the World Health Organization, each year cervical cancer impacts approximately 600,000 women throughout the ...

The condition is rare but a University of Illinois Chicago found the number of diagnosed cases jumped seven-fold from 2016 to ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could ...